Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company
focusing on creating value for people living with
neurology and immunology conditions.
Twitter Feed
-
We want to make sure that our efforts have a global impact 🌎: We work in resource-poor countries to improve the quality of life and provide access to neurological care for everyone 🤝. #corporateresponsibility https://t.co/rkaOAV4Cc8
— UCB News (@ucb_news) 20.06.2018 -
We’re returning home from #EULAR2018 feeling inspired to keep the momentum going for underserved patients and already looking forward to next year. See you in Madrid! https://t.co/xRGbsRGhD8
— UCB News (@ucb_news) 19.06.2018 -
Succeeding together: UCB joins patients and experts to improve the lives of people with epilepsy https://t.co/kwmtLkEgcj https://t.co/i3QFp2NI4p
— UCB News (@ucb_news) 19.06.2018